|
|
Home > Healthcare > Pharmaceutical > Drug Products
Pharmaceutical and healthcare market in Poland 2009
|
| Published Date:
June 2009
Published By:
PMR Ltd.
Order Code:
R320-164
|
|
|
|
- Report methodology
- Executive summary
- Overview of the pharmaceutical market in Poland
- Key events and trends in 2008-2009
- Key events and trends anticipated for 2009-2010
- Size of Polish pharmaceutical market
- Pharmaceutical market in 2002-2011
- Pharmacy sales in 2002-2008
- Development forecasts for pharmacy sales in 2009-2011
- Number of packages sold in 2002-2008
- Domestic and foreign pharmaceuticals
- Original and generic pharmaceuticals
- Overview of the hospital drug market in Poland
- Value of hospital market in 2000-2010
- Financial standing of public healthcare facilities
- Drug therapy programmes
- Spending on chemotherapy
- Drug prices
- Average drug prices on the pharmacy market
- Average drug prices on the hospital market
- Average prices of domestic and foreign pharmaceuticals
- Prices on aggregate pharmacy market
- Prices of Rx drugs
- Prices of refunded drugs
- Average prices of innovative and generic drugs
- Average prices in therapeutic groups
- Analysis of ATC groups, showcasing Rx drugs
- Analysis of ATC subgroups, showcasing Rx drugs
- Average prices of concern drugs
- Prices on the pharmacy market
- Rx drug prices
- Drug prices in Poland and in other European countries
- Drug reimbursement in Poland
- NFZ expenditure on drug reimbursement
- Share of reimbursement in pharmacy trade
- Structure of drug reimbursement
- Reimbursement structure by reimbursement type
- Reimbursement structure by therapeutic groups
- Reimbursement structure by domestic and foreign drugs
- Reimbursement structure by active substances
- Reimbursement structure by product
- Reimbursement structure by manufacturer
- Legislative changes and their impact on the drug reimbursement market
- New reimbursement lists
- Amendment to Pharmaceutical Law
- Foreign trade
- Export
- Import
- Pharmacy market by therapeutic groups
- Market value shares of ATC groups
- Pharmacy market
- Rx market
- Market volume shares of ATC groups
- Pharmacy market
- Rx market
- Alimentary tract and metabolism
- Market size and forecasts
- Key categories of drugs used in alimentary tract and metabolic diseases
- Drugs used in diabetes
- Vitamins and mineral supplements
- Antacids, antiflatulents and anti-ulcerants
- Antidiarrhoeals, oral electrolyte replacers and intenstinal anti-inflammatories
- Antiobesity preparations
- Best selling preparations
- Cardiovascular system
- Market size and forecasts
- Key categories of drugs used in cardiovascular diseases
- Agents acting on the renin-angiotensin system
- Lipid regulators
- Beta blocking agents
- Antihypertensives
- Best selling preparations
- Central nervous system
- Market size and forecasts
- Key categories of drugs used in central nervous system diseases
- Analgesics
- Psycholeptics
- Psychoanaleptics
- Best selling preparations
- Respiratory system
- Market size and forecasts
- Key categories of drugs used in respiratory system diseases
- Anti-asthma and COPD products
- Cough and cold preparations
- Systemic antihistamines
- Nasal preparations
- Best selling preparations
- Anti-infectives
- Market size and forecasts
- Key categories of anti-infectives
- Systemic antibacterials
- Vaccines
- Best selling preparations
- Musculo-skeletal system
- Market size and forecasts
- Key categories of drugs used in musculo-skeletal diseases
- Anti-inflammatory and anti-rheumatic products
- Topical anti-rheumatics
- Drugs for disorders of the musculo-skeletal system
- Best selling preparations
- Genito-urinary system
- Market size and forecasts
- Key categories of drugs affecting genito-urinary system
- Sex hormones and products with similar desired effects, systemic use only
- Urologicals
- Best selling preparations
- Dermatologicals
- Market size and forecasts
- Key categories of dermatologicals
- Topical corticosteroids
- Dermatological antifungals
- Best selling preparations
- Blood and blood forming organs
- Market size and forecasts
- Key categories of drugs used in diseases of the blood and blood forming organs
- Antithrombotic agents
- Anti-anaemic preparations
- Best selling preparations
- Antineoplastic and immunomodulating agents
- Market size and forecasts
- Key categories of antineoplastic and immunomodulating agents
- Cytostatic hormone therapy
- Immunostimulating agents
- Immunosuppressants
- Best selling preparations
- Other ATC groups
- Sensory organs
- Systemic hormonal preparations
- Parasitology
- Various
- Pharmaceutical companies in Poland
- Number and classification of pharmaceutical manufacturers in Poland
- Manufacturers of pharmaceutical substances
- Drug manufacturers
- Economic analysis of Polish pharmaceutical sector
- Output of selected pharmaceutical products
- Revenues
- Profit
- Operating expenses
- Employment
- Staffing levels
- Labour productivity
- Average remuneration
- Investments in the Polish pharmaceutical sector in 2006
- Investment number
- Investment value
- Largest foreign investments in Polish pharmaceutical industry 2007-2008
- Expenditure on intangible fixed assets
- Top drug makers in Poland
- Top players on pharmacy market
- Top players on the Rx market
- Profiles of key players
- Demographic trends
- Population
- Natural population growth
- Ageing of society
- Life expectancy
- Gender structure
- Degree of urbanisation
- Epidemiological trends
- The main health problems of Poles
- Main causes of death
- Key statistics
- Poland compared with other European countries
- Epidemiology of selected diseases in Polish society
- Cardiovascular system diseases
- Neoplasms
- Diseases of the central nervous system
- Respiratory system diseases
- Diseases of the alimentary tract and metabolism
- Consumer behaviour
- Health assessment
- What do Poles do to be healthy?
- Sources of information about health and illnesses
- Poles’ opinion about generic drugs
- Poles’ opinions about innovative drugs
- Factors influencing the purchase of OTC drugs
- Frequency of OTC drug purchases
- Most popular OTC drugs
- Place of purchase of OTC drugs
- Drug use in illness
- Macroeconomic trends
- GDP growth
- Inflation
- Unemployment
- Wages
- Regulatory environment
- Regulations and institutions governing the pharmaceutical market in Poland
- Key changes introduced by the “large amendment” to the Pharmaceutical Law
- Key changes introduced by the amended Healthcare Act
- Anti-corruption provisions
- Changes in reimbursement process
- Greater control over the NFZ
- Ordinance on Drug Advertising
- Visits of medical representatives at public healthcare centres
- Simultaneous advertising of several products
- Risk warnings
- Ban on audiovisual advertising in pharmacies
- Compliance with Medicinal Product Characteristics
- Transition provisions
- Key amendments introduced by the “minor amendment” to the Pharmaceutical Law
- Fixed prices and margins for reimbursed drugs
- Anti-concentration regulations
- Ban on advertising pharmacies
- Changes in monitoring adverse reactions
- Other regulations
- Harmonisation of registration documentation
- URPL Act
- Distribution
- Key events and trends on the distribution market in 2007-2009
- Trends expected on the distribution market in 2009-2011
- Key players on the drug distribution market
- Pharmaceutical wholesalers
- Wholesalers in Poland: number and business profiles
- The largest players on the Polish wholesale market
- Pharmacy distribution
- Pharmacy count
- Financial standing of Polish pharmacies
- Pharmacy chains
- Internet pharmacies
- Healthcare market in Poland
- Healthcare system in Poland
- Sources of financing of the public healthcare system
- Healthcare financing
- Healthcare costs
- Market of private medical services in Poland
- Other data on health care in Poland
- List of graphs
- List of tables
- About PMR
- About PharmaExpert
|
Similar Products
• Snapshots US Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Pharmaceuticals Industry Report
Published Nov 2009 by Plimsoll Publishing Ltd.
• Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis
Published Nov 2009 by Aruvian's R'search
• Pharmaceutical Industry in Mexico
Published Nov 2009 by Aruvian's R'search
• Antipsychotics Market Forecast
Published Oct 2009 by Datamonitor
• Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes
Published Oct 2009 by Datamonitor
• Prescription Drug Wholesaling in the US - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
• Antidepressants Market Forecast
Published Oct 2009 by Datamonitor
• Snapshots Bulgaria Pharmaceuticals 2009
Published Oct 2009 by Snapdata International Group
• Snapshots France Pharmaceuticals 2009
Published Oct 2009 by Snapdata International Group
|
|
|
|
0 items
